Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 31 July 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The amino acid and chemical products businesses are performing well, supported by strong demand, and sales are expected to exceed the previous forecast. Meanwhile, as the profitability of products for electronic materials is still improving and the increase in various costs, including raw material, fuel and logistics expenses, due to the prolonged situation in the Middle East is expected to weigh on profit, operating profit, ordinary profit and net income will remain at the same levels as in the previous forecast.
| Item | Details |
|---|---|
| Net Sales | ¥16,000 million → ¥17,700 million（+10.6%） |
| Operating profit | ¥550 million → ¥550 million（0.0%） |
| Ordinary income | ¥500 million → ¥500 million（0.0%） |
| Profit attributable to owners of the parent | ¥600 million → ¥600 million（0.0%） |
| Net income per share | 27 yen 76 sen → 27 yen 76 sen（0.0%） |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 31 July 2026 |
| Previous-period results | Fiscal year ending March 2026: sales ¥15,448 million, operating profit ¥383 million, ordinary profit ¥303 million, net income ¥313 million, net income per share ¥14.51, dividends ¥10.00 |
| Reason for the revision | The amino acid and chemical products businesses are performing well, supported by strong demand, and sales are expected to exceed the previous forecast. Meanwhile, as the profitability of products for electronic materials is still improving and the increase in various costs, including raw material, fuel and logistics expenses, due to the prolonged situation in the Middle East is expected to weigh on profit, operating profit, ordinary profit and net income will remain at the same levels as in the previous forecast. |
| Dividend forecast revision | Previous forecast: ¥10.00; revised forecast: ¥10.00; unchanged |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is because strong demand continues in the amino acid and chemical products businesses, and sales are expected to exceed the previous forecast. Meanwhile, forecasts for profit remain unchanged because, although the increase in sales is expected to contribute to profit, the profitability of products for electronic materials is still improving and costs including raw material, fuel and logistics expenses are rising amid the prolonged situation in the Middle East.